NCT01561898View on ClinicalTrials.gov

A Long-Term Study of JNS007ER in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone extended-release (JNS007ER)

Type= range, unit= mg, number= 3-12, form= tablet, route= oral use. JNS007ER within the range of 3, 6, 9 and 12 mg will be orally administered once daily for 48 weeks.

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY